Will Avandia Return? A Live Blog Of Today's FDA Advisory Committee

A panel of advisers to the Food and Drug Administration is deliberating whether to lift restrictions that have caused the diabetes drug Avandia, made by GlaxoSmithKline, to go from being the most-used diabetes pill to a product used by only 3,000 patients. They could also withdraw the drug, or leave things as they are. The reason for the the debate is a new analysis of an existing clinical trial that may indicate that Avandia does not raise the risk of death.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news